Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Tom Williams

Tom Williams

Life Sciences Professional Services Project Manager

Connect with Tom Williams on LinkedIn
Website:

About the author: Tom Williams, Ph.D., Life Sciences Professional Services, is a Life Sciences Project Manager, Knowledge Manager, and Research Scientist. He has extensive experience as an academic researcher in neurodegeneration and Alzheimer’s disease. He is also in skilled biophysical chemistry, dementia disorders, and biochemistry. He is the author of many publications in the field of Alzheimer’s disease. At Elsevier he delivers and implements information solutions for customers.

Posts by Tom Williams

phactMI: Delivering accurate drug information to point of care, part II

Posted on March 31st, 2021 in Medical Information

Part 2: The challenges that can restrict access to the latest and most accurate information on medications

Healthcare professionals are the ones tasked with safely prescribing, dispensing and managing medications. As mentioned in part 1 of this series, that puts them in the position of needing to know — or being able to quickly check — the latest information about a huge number of new and existing medical products.

(more…)

phactMI: Delivering accurate drug information to point of care

Posted on March 2nd, 2021 in Medical Information

Part 1: How healthcare professionals can access the latest and most accurate information on medications

Access to accurate, up-to-date information on medications helps healthcare professionals make better decisions. Before prescribing or dispensing a drug, it’s essential to have some insight into its behaviors — desired effect, required storage conditions, potential off-target effects, drug–drug interactions and so on. Physicians, nurse practitioners and pharmacy staff members demonstrate an incredible knowledge of drugs, built up through many years of point-of-care experience. This knowledge informs their clinical decisions.

(more…)

New Report on Melanoma Research: 3 Key Findings

Posted on December 13th, 2019 in Pharma R&D

The current state of melanoma research: insight & analytics, a new report released by Elsevier’s Life Sciences Professional Services, examines the landscape of melanoma R&D and reveals some very interesting findings.

(more…)

New Study Offers Insight into Alzheimer’s Disease Research Landscape

Posted on September 9th, 2019 in Pharma R&D

The sixth leading cause of death in the U.S., and estimated to affect approximately 45 million people worldwide, Alzheimer’s is a progressive brain disease that causes memory loss and overall mental deterioration. Coinciding with World Alzheimer’s Month, Elsevier just released a report (which you can download here) analyzing Alzheimer’s research spanning the last 50 years in order to present a comprehensive overview of the research landscape for this irreversible condition.

(more…)